Published on 8 Aug 2022 on Zacks via Yahoo Finance
DermTech, Inc. (DMTK) Reports Q2 Loss, Lags Revenue Estimates
DermTech, Inc. (DMTK) came out with a quarterly loss of $0.99 per share versus the Zacks Consensus Estimate of a loss of $1.02. This compares to loss of $0.48 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 2.94%. A quarter ago, it was expected that this company would post a loss of $0.85 per share when it actually produced a loss of $1.01, delivering a surprise of -18.82%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.